Last reviewed · How we verify
blood
At a glance
| Generic name | blood |
|---|---|
| Also known as | RBC product, Reb Blood Cells, injection of autologous blood |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Modality | Biologic |
| Therapeutic area | Hematology |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Effects on Blood Pressure, Cardiorespiratory Condition and Cardiovascular Risk of Different Aerobic Exercise Programs With Nutritional Interventions in Hypertensive and Overweight People. (NA)
- A Multicenter Open-label Phase 1 Trial to Evaluate Safety and Preliminary Efficacy of Endovascularly Applied Vascular Targeted Photodynamic Therapy (VTP) for Patients With Locally Advanced Unresectabl (Phase 1)
- Diagnostic and PROgnostic BIOmarkers Before and After Kidney Transplantation (N/A)
- The Effects of PVC Suppression on Blood Pressure Control in Patients With Frequent PVCs (Phase 2)
- A Phase III, Randomized, Double-blind, Controlled Multicenter Study of Intravenous PI3K Inhibitor Copanlisib in Combination With Standard Immunochemotherapy Versus Standard Immunochemotherapy in Patie (Phase 3)
- Cellular Mechanisms for Metabolic Dysfunction in HIV (Phase 1)
- Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (Phase 2)
- Sudden Cardiac Death in Congenital Heart Diseases With a Systemic Right Ventricle (N/A)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |